CHANDLER DIFFILY: Open Payments
NPI 1487270112 · HAVERHILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 9 payments from 6 companies in 2025. Trend: 2023 $162 · 2024 $634 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $54 |
| Lundbeck LLC | 2 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: REXULTI, UZEDY, INGREZZA, VRAYLAR, TRINTELLIX.
Industry payments across MA — which companies pay providers there.
